Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/22/24 16:03 | 11/19/24 | INBX | Health | BioPrd | Biological Products, (No Diag | Kayyem Jon Faiz | CA | D | 3 | P.m | 7,448 | 16.50 | 0 | 452 | 65 | 1,150 | I | |||||||||||||||
9/16/24 17:12 | 9/12/24 | INBX | Health | BioPrd | Biological Products, (No Diag | Lappe Mark | CA | DO | CEO | 4 | P.m | 2,415 | 14.73 | 0 | 164 | 22 | 925 | I | ||||||||||||||
9/12/24 17:14 | 9/10/24 | INBX | Health | BioPrd | Biological Products, (No Diag | Vuori Kristiina Md | CA | D | 2 | P.m | 200 | 14.51 | 0 | 14 | 14 | D | ||||||||||||||||
8/30/24 16:16 | 8/28/24 | INBX | Health | BioPrd | Biological Products, (No Diag | Manhard Kimberly | CA | D | 1 | P | 140 | 13.98 | 0 | 10 | 10 | I | ||||||||||||||||
8/26/24 16:26 | 8/22/24 | INBX | Health | BioPrd | Biological Products, (No Diag | Forsyth Douglas | CA | D | 1 | P.m | 1,037 | 13.83 | 0 | 75 | 50 | 225 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |